<b>Arteriovenous fistula creation results in cardiac dysfunction and remodeling in a uremic pig model</b>

<b>Arteriovenous fistula creation results in cardiac dysfunction and remodeling in a uremic pig model</b>

<p dir="ltr"><b>The arteriovenous fistula (AVF) is required for hemodialysis in end-stage kidney disease (ESKD). AVF creation results in compensatory cardiovascular hemodynamics, which are subsequently associated with cardiac remodeling. Relatedly, cardiovascular mortality and...

保存先:

書誌詳細
第一著者:	Jamie Kane (22633352) (author)
出版事項:	2025
主題:	Cardiology (incl. cardiovascular diseases) arteriovenous fistulae (AVFs) Cardiac remodelling and fibrosis fibrosis senescence
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

<b>Figure S1.</b><b> Cardiac MRI LV volume responses to EX and MMA in</b><b> </b><b>i</b><b>sometric handgrip force-matched-matched males and females</b>
著者:: Corey Tomczak (22648301)
出版事項: (2025)

Impact of autonomic dysfunction in light chain amyloidosis patient with nephrotic syndrome and cardiac involvement
著者:: Hamza Sakhi (20837019)
出版事項: (2025)

Table 1_Association between spicy food consumption and the risk of non-alcoholic fatty liver disease/metabolic dysfunction-associated steatotic liver disease and liver fibrosis.docx
著者:: Na Zhao (112953)
出版事項: (2025)

Image 1_Association between spicy food consumption and the risk of non-alcoholic fatty liver disease/metabolic dysfunction-associated steatotic liver disease and liver fibrosis.tif
著者:: Na Zhao (112953)
出版事項: (2025)

Military Heart Trauma: Endoscopic Extraction of a Cardiac Foreign Body
著者:: Glib Yemets (16897609)
出版事項: (2025)

Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx
著者:: Rou Li (11575418)
出版事項: (2025)

Table 1_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx
著者:: Rou Li (11575418)
出版事項: (2025)

Image 1_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.tif
著者:: Rou Li (11575418)
出版事項: (2025)

Image 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.tif
著者:: Rou Li (11575418)
出版事項: (2025)

<b>Figure S2.</b> <b>Cardiovascular hemodynamic responses to EX and MMA in</b><b> </b><b>i</b><b>sometric handgrip force-matched males and females</b>
著者:: Corey Tomczak (22648301)
出版事項: (2025)

Dataset generated and used for <i>“A unified framework for geometry-independent operator learning in cardiac electrophysiology simulations”</i>
著者:: Bei Zhou (22682549)
出版事項: (2025)

Data Sheet 1_Myosteatosis as an independent predictor for all-cause and cardiac mortality in initial-dialysis patients: a multicenter, retrospective cohort study.pdf
著者:: Shi-Mei Hou (22686284)
出版事項: (2025)

Table 1_Association of triglyceride-glucose index and remnant cholesterol levels with liver fibrosis progression and disease severity in patients with non-alcoholic fatty liver disease: a cross-sectional study.docx
著者:: Qiong Duan (4693000)
出版事項: (2025)

Supplementary file 1_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.docx
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 1_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Supplementary file 2_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.xlsx
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 3_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 2_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 5_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 4_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 7_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.pdf
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 6_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.pdf
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 8_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 11_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 10_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 9_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Table 12_Resveratrol attenuates pulmonary fibrosis by inhibiting alveolar epithelial senescence via targeting SASP-related proteins: an integrated bioinformatics-experimental study.csv
著者:: Biao Zuo (1529497)
出版事項: (2025)

Supplementary file 2_Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway.docx
著者:: Junming Xu (1716112)
出版事項: (2025)

Supplementary file 1_Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway.zip
著者:: Junming Xu (1716112)
出版事項: (2025)

Table 1_Is conduction system pacing improving cardiac performance in patients with right bundle branch block and heart failure?.doc
著者:: Jia Jing-Jing (22678646)
出版事項: (2025)

Data Sheet 1_Impact of individualized and structured aerobic exercise on clinical outcomes in pediatric congenital heart diseases with post-surgical rehabilitation: a meta-analysis.docx
著者:: Ayoola Awosika (22687004)
出版事項: (2025)

Medication-inclusive multivariable logistic regression for MAFLD.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Multivariable logistic regression models for MAFLD predictors.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64).
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Liver Stiffness and Fibrosis Grading by MAFLD Status.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Comparison of Non-invasive Liver Fibrosis Scores.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Demographic and Clinical Characteristics of Study Participants.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Proposed pathophysiological crosstalk between MAFLD and CKD.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Stratification of Liver Stiffness according to eGFR in the MAFLD group.
著者:: Zienab M. Saad (22676502)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_e51lmhgatbvkvqf7ignom47n21